Treat every efficacy statement here as studies suggest or in animal models, never as established human benefit
Global NASH Council, American Association for the Study of Liver Diseases (AASLD), EASL | The Home of Hepatology, Canadian Association for the Study of the Liver, European Liver Patients' Association - ELPA, Global Liver Institute, Priti Chawla, Obesity Matters, American Diabetes Association Fatty Liver Alliances Post GLP-1 receptor agonists (GLP-1RAs) show promise in managing metabolic dysfunction-associated steatotic liver disease (MASLD) by reducing hepatic steatosis, resolving MASH, and mitigating fibrosis progression
plant: diversity, antioxidant, and antibacterial activities of their ethyl acetate extracts
2025 (Frontiers in Nutrition) Cross-sectional dietary study of 69 GLP-1 users
From this point on, production deteriorates quite steadily